How should fifth disease (erythema infectiosum) be managed in children, and what precautions are needed for pregnant contacts?

Fifth Disease (Erythema Infectiosum) Management

Fifth disease in children requires only supportive care with no specific treatment, but pregnant contacts without immunity need urgent serologic testing and fetal surveillance if infected, as parvovirus B19 can cause severe fetal anemia and hydrops fetalis with mortality rates of 15% at 13-20 weeks gestation.

Management in Children

Fifth disease is a self-limited viral exanthem caused by parvovirus B19 that resolves spontaneously without intervention 1, 2.

Clinical Recognition

• Classic presentation: "Slapped cheek" appearance on face, followed by lacy/reticulated rash on trunk and extremities (sparing palms and soles)
• Rash evolution: Three stages over approximately 3 weeks with spontaneous resolution
• Prodrome: Mild symptoms (low-grade fever, headache, malaise) 4-14 days after exposure
• Pruritus: Occurs in approximately 50% of cases 1

Treatment Approach

• Symptomatic management only: Antipyretics for fever, antihistamines for pruritus if needed
• No isolation required: Children are no longer contagious once the rash appears 1, 2
• Reassurance: Excellent prognosis in immunocompetent children with self-limited course 2

Potential Complications to Monitor

• Arthralgia/arthritis: More common in adults than children
• Transient aplastic crisis: Only in children with underlying hemolytic anemia (sickle cell disease, hereditary spherocytosis)
• Chronic anemia: Only in immunocompromised patients 1

Critical Precautions for Pregnant Contacts

This is where fifth disease becomes a serious concern requiring immediate action.

Risk Assessment

The highest fetal risk occurs with maternal infection at 13-20 weeks gestation, with a 2% risk of congenital complications and 15% fetal death rate 3. After 20 weeks, fetal death risk drops to 6% 3.

Immediate Steps for Pregnant Contacts

Step 1: Determine immune status immediately

• Order parvovirus B19 IgG and IgM antibodies urgently 4, 5
• If IgG positive: Patient is immune; no further action needed, risk is zero 5
• If IgG negative: Patient is susceptible and requires close monitoring

Step 2: For non-immune pregnant women with exposure

• Repeat serology in 2-4 weeks to detect seroconversion 5
• If IgM positive: Confirms acute infection; proceed to fetal surveillance

Step 3: Fetal surveillance protocol for infected mothers

• Serial ultrasound examinations every 1-2 weeks for 8-12 weeks 4
• Doppler measurements of peak systolic velocity in middle cerebral artery to detect fetal anemia 4
• Monitor for signs of hydrops fetalis (fluid accumulation in fetal compartments) 3

Step 4: Referral for complications

• Immediate referral to maternal-fetal medicine if hydrops fetalis develops or severe fetal anemia is suspected 3, 4
• Intrauterine fetal blood transfusion can be lifesaving and significantly improves outcomes 3
• Fetal transfusion is recommended unless pregnancy is at advanced gestational age where delivery risks are lower than procedure risks 3

Common Pitfalls to Avoid

• Do not dismiss pregnant contacts: Approximately 40% of childbearing-age women remain non-immune 4
• Do not rely on symptoms in adults: Adults are often asymptomatic or have atypical presentations (joint pain without rash) rather than the classic slapped-cheek appearance 1, 4
• Do not delay serologic testing: The window for intervention is narrow, particularly in second trimester
• Do not assume immunity: Only serologic confirmation of IgG positivity guarantees protection 5

Key Distinction from Other Exanthems

The reticulated/lacy pattern helps distinguish fifth disease from other viral exanthems in 80% of cases 1. However, when in doubt with a pregnant contact, test serologically rather than relying on clinical diagnosis alone.